AKTX

Akari Therapeutics
AKTX

14 hedge funds and large institutions have $1.18M invested in Akari Therapeutics in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$782K
2
+$21.9K
3
+$19.2K
4
IAA
Independent Advisor Alliance
North Carolina
+$10.6K

Top Sellers

1
-$210K
2
-$33.3K
3
-$20.4K
4
EWA
EverSource Wealth Advisors
Alabama
-$4.2K
5
UBS Group
UBS Group
Switzerland
-$2.02K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Cresset Asset Management
Illinois
$831K
PAI
2
Palo Alto Investors
California
$147K
HighTower Advisors
3
HighTower Advisors
Illinois
$80K
OFW
4
Omnia Family Wealth
Florida
$28.7K
Cerity Partners
5
Cerity Partners
New York
$23.9K
VF
6
Virtu Financial
New York
$22K
TSS
7
Two Sigma Securities
New York
$20K
IAA
8
Independent Advisor Alliance
North Carolina
$11K
ACM
9
Accent Capital Management
Ohio
$10.1K
NA
10
NewEdge Advisors
Louisiana
$6.87K
CPG
11
Cornerstone Planning Group
New Jersey
$285
Bank of America
12
Bank of America
North Carolina
$152
UBS Group
13
UBS Group
Switzerland
$61
TC
14
Truvestments Capital
Florida
$51
EWA
15
EverSource Wealth Advisors
Alabama
$44
Morgan Stanley
16
Morgan Stanley
New York
$3
SM
17
Sabby Management
Florida
–
Renaissance Technologies
18
Renaissance Technologies
New York
–